Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code

CHEN Chunjuan, ZHENG Zhixin, LI Li. Clinical curative effect of Pingchuan prescription combined with montelukast sodium on patients with bronchial asthma[J]. Journal of Pharmaceutical Practice and Service, 2024, 42(12): 524-527, 532. doi: 10.12206/j.issn.2097-2024.202405035
Citation: ZHU Leilei, GUO Lixia, ZHAN Yan, QIU Furong, ZHAO Tongfang, YE Yujie, YUAN Wei'an, LI Anping, LI Minghua, SU Shufang, JIANG Jian. Bioequivalence study on two terazosin hydrochloride tablets[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(5): 419-422. doi: 10.3969/j.issn.1006-0111.2015.05.009

Bioequivalence study on two terazosin hydrochloride tablets

doi: 10.3969/j.issn.1006-0111.2015.05.009
  • Received Date: 2014-09-26
  • Rev Recd Date: 2015-03-31
  • Objective To evaluate the bioequivalence of domestic and imported terazosin hydrochloride tablets after single oral dose. Methods It was a single center, randomized, open, cross-over trail design, 21 subjects were fasting oral administered of 2 mg domestic and imported terazosin hydrochloride tablets in different periods, venous blood 4 ml were collected in different time points before and 60 h after administration, plasma concentration of terazosin was determined by LC-MS/MS. Results The main pharmacokinetic parameters of domestic and imported terazosin hydrochloride tablets were as follows:t1/2 : (13.2± 2.39) h vs (12.5±1.93) h, tmax: (1.01±0.83) h vs (1.08±0.69) h, Cmax: (40.1±10.6) ng/ml vs (37.3±9.57) ng/ml; AUC0- ∞: (428±82.1) ng·h/ml vs (426±85.2) ng·h/ml. The relative bioavailability of domestic terazosin hydrochloride tablets was (101.2±14.7)%. 90% CI of domestic and imported terazosin hydrochloride tablets AUC0-t and Cmax geometric mean ratio fell between 80%-125%. Conclusion The domestic tablets are bioequivalent to the imported tablets.
  • [1] 祝凌飞. 特拉唑嗪治疗良性前列腺增生疗效Meta分析[J].中国药房,2013,24(24):2279-2282.
    [2] 国家药典委员会. 中华人民共和国药典2010年版二部[S]. 北京: 中国医药科技出版社,2010: 附录195-199.
    [3] 顾逸敏,姚 蓝,刘艳梅,等.进口和国产盐酸特拉唑嗪片的人体生物等效性研究[J].药学服务与研究,2009,9(5):370-373.
    [4] 陈 钧,陆 伟,史振祺,等.两种盐酸特拉唑嗪片剂人体生物等效性评价[J].中国药学杂志,2003,38(6):446-448.
  • Created with Highcharts 5.0.7Amount of accessChart context menuAbstract Views, HTML Views, PDF Downloads StatisticsAbstract ViewsHTML ViewsPDF Downloads2024-052024-062024-072024-082024-092024-102024-112024-122025-012025-022025-032025-0400.250.50.7511.25Highcharts.com
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 79.8 %FULLTEXT: 79.8 %META: 15.9 %META: 15.9 %PDF: 4.3 %PDF: 4.3 %FULLTEXTMETAPDFHighcharts.com
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 18.4 %其他: 18.4 %China: 0.7 %China: 0.7 %India: 5.1 %India: 5.1 %Mexico: 1.4 %Mexico: 1.4 %United States: 0.4 %United States: 0.4 %[]: 2.9 %[]: 2.9 %上海: 1.8 %上海: 1.8 %凉山: 0.4 %凉山: 0.4 %北京: 17.0 %北京: 17.0 %张家口: 1.4 %张家口: 1.4 %成都: 1.1 %成都: 1.1 %杭州: 1.1 %杭州: 1.1 %石家庄: 1.8 %石家庄: 1.8 %芒廷维尤: 29.2 %芒廷维尤: 29.2 %西宁: 14.1 %西宁: 14.1 %贵阳: 0.4 %贵阳: 0.4 %运城: 0.4 %运城: 0.4 %重庆: 0.4 %重庆: 0.4 %长治: 0.4 %长治: 0.4 %阳泉: 0.4 %阳泉: 0.4 %鸡西: 0.4 %鸡西: 0.4 %黄冈: 1.1 %黄冈: 1.1 %其他ChinaIndiaMexicoUnited States[]上海凉山北京张家口成都杭州石家庄芒廷维尤西宁贵阳运城重庆长治阳泉鸡西黄冈Highcharts.com
  • Cited by

    Periodical cited type(1)

    1. 张培雯,樊莲莲,甘春燕,申屠建中. 中国健康受试者中特拉唑嗪的安全性分析. 实用医院临床杂志. 2023(04): 82-85 .

    Other cited types(0)

通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Article Metrics

Article views(3421) PDF downloads(507) Cited by(1)

Related
Proportional views

Bioequivalence study on two terazosin hydrochloride tablets

doi: 10.3969/j.issn.1006-0111.2015.05.009

Abstract: Objective To evaluate the bioequivalence of domestic and imported terazosin hydrochloride tablets after single oral dose. Methods It was a single center, randomized, open, cross-over trail design, 21 subjects were fasting oral administered of 2 mg domestic and imported terazosin hydrochloride tablets in different periods, venous blood 4 ml were collected in different time points before and 60 h after administration, plasma concentration of terazosin was determined by LC-MS/MS. Results The main pharmacokinetic parameters of domestic and imported terazosin hydrochloride tablets were as follows:t1/2 : (13.2± 2.39) h vs (12.5±1.93) h, tmax: (1.01±0.83) h vs (1.08±0.69) h, Cmax: (40.1±10.6) ng/ml vs (37.3±9.57) ng/ml; AUC0- ∞: (428±82.1) ng·h/ml vs (426±85.2) ng·h/ml. The relative bioavailability of domestic terazosin hydrochloride tablets was (101.2±14.7)%. 90% CI of domestic and imported terazosin hydrochloride tablets AUC0-t and Cmax geometric mean ratio fell between 80%-125%. Conclusion The domestic tablets are bioequivalent to the imported tablets.

CHEN Chunjuan, ZHENG Zhixin, LI Li. Clinical curative effect of Pingchuan prescription combined with montelukast sodium on patients with bronchial asthma[J]. Journal of Pharmaceutical Practice and Service, 2024, 42(12): 524-527, 532. doi: 10.12206/j.issn.2097-2024.202405035
Citation: ZHU Leilei, GUO Lixia, ZHAN Yan, QIU Furong, ZHAO Tongfang, YE Yujie, YUAN Wei'an, LI Anping, LI Minghua, SU Shufang, JIANG Jian. Bioequivalence study on two terazosin hydrochloride tablets[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(5): 419-422. doi: 10.3969/j.issn.1006-0111.2015.05.009
Reference (4)

Catalog

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return